175 related articles for article (PubMed ID: 23202785)
1. Synchronous metastasis from lobular carcinoma and primary carcinoma of the endometrium in a patient after tamoxifen therapy.
Vicioso L; Ortega MV; Cívico V; López-Beltrán A
Int J Gynecol Pathol; 2013 Jan; 32(1):66-70. PubMed ID: 23202785
[TBL] [Abstract][Full Text] [Related]
2. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
[TBL] [Abstract][Full Text] [Related]
3. Lobular carcinoma metastasis to endometrial polyp unrelated to tamoxifen. Report of a case and review of the literature.
Manipadam MT; Walter NM; Selvamani B
APMIS; 2008 Jun; 116(6):538-40. PubMed ID: 18754330
[TBL] [Abstract][Full Text] [Related]
4. Metastatic lobular breast carcinoma to an endometrial polyp diagnosed by hysteroscopic biopsy.
Alvarez C; Ortiz-Rey JA; Estévez F; de la Fuente A
Obstet Gynecol; 2003 Nov; 102(5 Pt 2):1149-51. PubMed ID: 14607038
[TBL] [Abstract][Full Text] [Related]
5. Metastasis from breast carcinoma to a tamoxifen-related endometrial polyp.
Acikalin MF; Oner U; Tekin B; Yavuz E; Cengiz O
Gynecol Oncol; 2005 Jun; 97(3):946-8. PubMed ID: 15896832
[TBL] [Abstract][Full Text] [Related]
6. Relationship between tamoxifen use and high risk endometrial cancer histologic types.
Bland AE; Calingaert B; Secord AA; Lee PS; Valea FA; Berchuck A; Soper JT; Havrilesky L
Gynecol Oncol; 2009 Jan; 112(1):150-4. PubMed ID: 18937966
[TBL] [Abstract][Full Text] [Related]
7. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
Cheng WF; Lin HH; Torng PL; Huang SC
Gynecol Oncol; 1997 Aug; 66(2):233-7. PubMed ID: 9264568
[TBL] [Abstract][Full Text] [Related]
8. Metastasis of lobular breast cancer to endometrial polyps with and without the presence of vaginal bleeding.
Martinez MR; Marazuela MA; Vallejo MR; Bernabeu RÁ; Medina TP
Int J Gynaecol Obstet; 2016 Jul; 134(1):101-2. PubMed ID: 27045079
[No Abstract] [Full Text] [Related]
9. Metastatic breast lobular carcinoma to tamoxifen-associated endometrial polyp: case report and literature review.
Al-Brahim N; Elavathil LJ
Ann Diagn Pathol; 2005 Jun; 9(3):166-8. PubMed ID: 15944961
[TBL] [Abstract][Full Text] [Related]
10. Papillary serous carcinoma of the peritoneum coexisting with or after endometrial carcinoma.
Altaras MM; Bernheim J; Zehavi T; Drucker L; Uziel O; Fishman A
Gynecol Oncol; 2002 Feb; 84(2):245-51. PubMed ID: 11812082
[TBL] [Abstract][Full Text] [Related]
11. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium.
Farrell R; Scurry J; Otton G; Hacker NF
Gynecol Oncol; 2005 Aug; 98(2):254-62. PubMed ID: 15936803
[TBL] [Abstract][Full Text] [Related]
13. Metastasis from breast lobular carcinoma to an endometrial polyp. Report of a case with immunohistochemical study.
Aranda FI; Laforga JB; Martinez MA
Acta Obstet Gynecol Scand; 1993 Oct; 72(7):585-7. PubMed ID: 8213111
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patients.
Ngô C; Brugier C; Plancher C; de la Rochefordière A; Alran S; Féron JG; Malhaire C; Scholl S; Sastre X; Rouzier R; Fourchotte V;
Eur J Surg Oncol; 2014 Oct; 40(10):1237-44. PubMed ID: 25086993
[TBL] [Abstract][Full Text] [Related]
15. Papillary-serous adenocarcinoma of the uterine cervix during tamoxifen therapy after bilateral breast cancer.
Watrowski R; Striepecke E; Jäger C; Bauknecht T; Horst C
Anticancer Res; 2012 Nov; 32(11):5075-8. PubMed ID: 23155282
[TBL] [Abstract][Full Text] [Related]
16. [Endometrial cancers arising in polyps associated with tamoxifen use].
Mbatsogo BA; Le Bouëdec G; Michy T; Bourdel N; Fouilloux G; Dauplat J
Gynecol Obstet Fertil; 2005 Dec; 33(12):975-9. PubMed ID: 16321556
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of WT-1 in serous carcinomas in the peritoneum with or without associated serous carcinoma in endometrial polyps.
Euscher ED; Malpica A; Deavers MT; Silva EG
Am J Surg Pathol; 2005 Aug; 29(8):1074-8. PubMed ID: 16006803
[TBL] [Abstract][Full Text] [Related]
18. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
[TBL] [Abstract][Full Text] [Related]
19. [Pathology of the endometrium in breast cancer patients treated with tamoxifen (nolvadex)].
Ivanova V; Karaivanov M; Marinov E; Gorchev G; Velkova A; Khristova P
Akush Ginekol (Sofiia); 2003; 42(5):3-8. PubMed ID: 14682005
[TBL] [Abstract][Full Text] [Related]
20. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
Otsuka I; Takahashi S; O'uchi K; Akimoto N; Hanari K; Ogaki Y; Enatsu YH; Takigawa A; Takaya H; Tanaka A; Kaseki H; Yamada T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):279-83. PubMed ID: 20154485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]